The prognostic significance and immune correlation of SLC10A3 in low-grade gliomas revealed by bioinformatic analysis and multiple immunohistochemistry
Figure 2.Distribution of SLC10A3 transcription among different clinical groups. (A) age. (B) gender. (C) race. (D) WHO grade. (E) IDH mutation status. (F) 1p19q co-deletion. (G) laterality. (H) histological type. (I) primary therapy outcome.